| Income Statement |
| Total Revenue | 179.00K |
|
| Revenues (USD) | 179.00K |
| Cost of Revenue | 179.00K |
| Operating Expenses | 2.62M |
| Research and Development Expense | 962.00K |
| Selling, General and Administrative Expense | 1.57M |
| Operating Income | -2.62M |
| Interest Expense | 436.00K |
| Net Income | -3.38M |
| Net Income Common Stock | -3.38M |
| Net Income Common Stock (USD) | -3.38M |
| Consolidated Income | -3.38M |
| Earnings per Basic Share | -0.07 |
| Earnings per Basic Share (USD) | -0.07 |
| Earnings per Diluted Share | -0.07 |
| Earning Before Interest & Taxes (EBIT) | -2.95M |
| Earning Before Interest & Taxes (USD) | -2.95M |
| Weighted Average Shares | 48.36M |
| Weighted Average Shares Diluted | 48.36M |
| Balance Sheet |
| Cash and Equivalents | 1.06M |
| Cash and Equivalents (USD) | 1.06M |
| Investments | 1.16M |
| Investments Non-Current | 1.16M |
| Trade and Non-Trade Receivables | 699.00K |
| Current Assets | 2.16M |
| Property, Plant & Equipment Net | 1.66M |
| Total Assets | 6.70M |
| Debt Current | 807.00K |
| Total Debt | 3.01M |
| Current Liabilities | 3.17M |
| Debt Non-Current | 2.21M |
| Total Liabilities | 18.72M |
| Accumulated Retained Earnings (Deficit) | -207.71M |
| Accumulated Other Comprehensive Income | -1.19M |
| Shareholders Equity | -12.02M |
| Shareholders Equity (USD) | -12.02M |
| Assets Non-Current | 4.55M |
| Total Debt (USD) | 3.01M |
| Deferred Revenue | 323.00K |
| Goodwill and Intangible Assets | 1.73M |
| Liabilities Non-Current | 15.55M |
| Trade and Non-Trade Payables | 2.96M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 84.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.29M |
| Capital Expenditure | -35.00K |
| Net Cash Flow from Investing | -35.00K |
| Net Cash Flow from Operations | -1.23M |
| Effect of Exchange Rate Changes on Cash | -29.00K |
| Share Based Compensation | 979.00K |